When the mice were exposed to DEN/DMH/DSS treatments that induce liver or colon cancer, there was a dramatic reduction in gross tumor size and number in the Smyd3-deficient group with only a few focal nodular hyperplastic areas detected histologically in the DEN-treated Smyd3-deficient mice. Here, SMYD3 is linked to neoplasm.